Cardiovascular Risk in Women With Fibroids: New Study Links Uterine Health to Heart Disease
Recent research has shed new light on the connection between uterine fibroids and cardiovascular risk in women. For years, fibroids have been understood mainly as benign reproductive health concerns. However, new large-scale data from the Journal of the American Heart Association highlights that women with fibroids are significantly more likely to develop heart disease. This connection reveals an urgent need to integrate uterine and cardiovascular health in clinical care. Understanding the cardiovascular risk in women with fibroids may help shape early prevention, screening, and treatment strategies for millions.
What Are Uterine Fibroids and Why Are They Common?
Uterine fibroids, also called leiomyomas or fibroid tumors, are noncancerous growths that form in the muscular wall of the uterus. According to the U.S. Office on Women’s Health, up to 80% of women may develop fibroids by age 50. While some experience heavy menstrual bleeding, pelvic pain, or reproductive issues, others have no symptoms at all. Despite their high prevalence, fibroids have historically received limited research attention. Scientists are now exploring how these seemingly isolated growths may influence broader body systems — particularly cardiovascular health.
Key Findings on Cardiovascular Risk in Women With Fibroids
A 2025 study of over 2.7 million U.S. women found that those diagnosed with fibroids were 81% more likely to develop cardiovascular disease over a 10-year period compared to women without fibroids. Cardiovascular disease in this context included coronary artery disease, cerebrovascular disease (such as stroke), and peripheral artery disease. The data also revealed critical subgroup differences. Women under 40 with fibroids had over a 3.5-fold higher cardiovascular risk. Asian women showed the highest relative risk within one year of diagnosis, while Black women had both the highest prevalence and a strong risk increase. These findings suggest that fibroids may serve as a marker for long-term vascular vulnerability.
Understanding the Atherosclerotic Connection
The study showed that uterine fibroids and atherosclerotic cardiovascular disease share several biological processes. These include smooth muscle proliferation, fibrosis, calcification, and systemic inflammation. These mechanisms promote the buildup of plaque and hardening of arteries. Both fibroid and vascular tissues exhibit similar molecular patterns involving inflammatory compounds such as interleukin-6 and tumor necrosis factor-alpha. This overlap may explain why fibroid growth correlates with increased risk for atherosclerosis and related heart problems.
Why Do Uterine Fibroids Increase Heart Disease Risk?
While fibroids themselves are localized to the uterus, their effects can extend beyond the pelvic region. Researchers have identified several pathways linking fibroids to heart disease.
1. The Role of Chronic Inflammation
Fibroids trigger a chronic inflammatory state that affects blood vessel function. Long-term inflammation contributes to the gradual damage of arterial walls, increasing the likelihood of hypertension and vascular inflammation. Over time, this can accelerate the development of atherosclerosis, increasing coronary artery disease risk.
2. Iron Deficiency Anemia and Cardiac Strain
Heavy menstrual bleeding, a common symptom of fibroids, can cause iron deficiency anemia. This condition reduces blood oxygen-carrying capacity, forcing the heart to work harder to supply oxygen. Chronic anemia may lead to fatigue and, if untreated, enlargement of the heart or even heart failure. Studies suggest that correcting iron deficiency in women with fibroids may reduce strain on the cardiovascular system and improve overall heart function.
3. Hypertension and Hormonal Links
Women with fibroids are more than twice as likely to develop hypertension. Elevated blood pressure may worsen fibroid growth by influencing vascular supply to uterine tissue, creating a self-reinforcing cycle. High blood pressure itself is a leading risk factor for cardiovascular disease and heart failure in women. Hormonal factors such as estrogen and progesterone, which influence fibroid growth, may also affect vascular tone and arterial health.
Do Uterine Fibroids Increase Heart Disease Risk Equally Across All Women?
One of the striking outcomes of recent research is that the cardiovascular risk associated with uterine fibroids affects women of all races but not equally. Younger women appear particularly vulnerable. Women under 40 were found to have a more than 250% increase in cardiovascular risk within the decade following a fibroid diagnosis. Black and Hispanic women, who already experience higher fibroid prevalence, may face compounded cardiovascular consequences due to socioeconomic disparities and reduced access to preventive care. Asian women showed the highest short-term risk in the first year post-diagnosis, pointing to potential genetic differences in inflammatory response or vascular sensitivity.
Age and Hormone-Related Factors
Premenopausal women frequently show a higher frequency of both fibroids and metabolic changes that affect heart disease risk. The hormonal balance that contributes to fibroid growth may also influence lipid metabolism and vascular elasticity. Postmenopausal women see reduced fibroid size, yet the cardiovascular risk may remain elevated due to persistent vascular remodeling.
How Should Heart Health Be Managed in Women Diagnosed With Fibroids?
For women with uterine fibroids, managing cardiovascular risk requires both gynecologic and cardiac care coordination. Medical professionals now emphasize the importance of early cardiovascular screening following a fibroid diagnosis.
Practical Prevention Strategies
Regular blood pressure monitoring: Early detection and control of hypertension can significantly lower cardiovascular disease risk.
Assess and manage anemia: Routine blood tests for hemoglobin and ferritin levels can identify iron deficiency early. Iron supplementation or minimally invasive fibroid treatments that reduce bleeding may help prevent cardiac strain.
Healthy lifestyle habits: A balanced diet rich in iron and vegetables, regular exercise, and maintaining a healthy weight support both uterine and heart health.
Cardiology consultation when indicated: Women with multiple fibroids, large fibroids, or histories of severe bleeding should consider a cardiovascular risk assessment, especially if they have a family history of heart disease.
Integrating Fibroid History Into Cardiac Risk Models
The new data suggests that including a woman’s fibroid history into cardiovascular risk prediction models could lead to earlier intervention. Researchers recommend future studies to assess whether fibroid size or treatment history modifies heart disease risk. Adding such factors into patient risk profiles could allow clinicians to customize prevention strategies for each individual.
The Bigger Picture — Reframing Fibroids Beyond Reproductive Health
These findings emphasize that fibroids are not merely a reproductive issue but a systemic condition influencing female cardiovascular health. Historically, gynecologic and cardiologic care have been approached separately. Integrating these specialties could improve heart disease prevention outcomes among women. Annual gynecologic checkups, often a woman’s main point of care, present excellent opportunities to discuss blood pressure, cholesterol, and heart disease symptoms. Educating women about the cardiovascular implications of fibroids also empowers them to be proactive about prevention.
What This Research Means for Women and Clinicians
The link between fibroids and heart disease risk has far-reaching implications for women’s health policy and clinical care. It calls for a multidisciplinary approach that bridges reproductive and cardiovascular medicine. For clinicians, these findings highlight the importance of asking about fibroid history when assessing cardiovascular risk. For women, it reinforces the need for routine cardiovascular monitoring, particularly when symptoms like fatigue, shortness of breath, or chest discomfort persist.
Ongoing Research and Clinical Outlook
Researchers at the University of Pennsylvania plan to expand their analyses by exploring whether certain fibroid treatments, such as uterine artery embolization or hormonal therapy, reduce long-term heart disease risk. They also call for public health initiatives to increase awareness among women and providers regarding this connection.
Conclusion
The emerging evidence around cardiovascular risk in women with fibroids marks a pivotal step toward understanding how uterine and cardiovascular health intersect. Women with fibroids face up to 81% higher risk of developing cardiovascular disease, and those under 40 show the strongest associations. By addressing inflammation, managing anemia, and monitoring blood pressure, healthcare providers can help reduce this risk. Moving forward, clinicians should view fibroids not simply as a reproductive concern but as an indicator of potential systemic and vascular issues. With proactive care and integrated prevention strategies, it is possible to improve outcomes for millions of women living with uterine fibroids.
Comments